Kimberly Luddy
@kimberly-luddy.bsky.social
Theoretical and experimental immunologist working in cancer research.
Moffitt Cancer Center
Moffitt Cancer Center
This announcement from the NIH is fantastic
“NIH will no longer seek proposals exclusively for animal models”
All new proposals should include modern alternatives: e.g. computational modeling and organoid style technologies with human components.
drugdiscoverytrends.com/nih-announces-…
“NIH will no longer seek proposals exclusively for animal models”
All new proposals should include modern alternatives: e.g. computational modeling and organoid style technologies with human components.
drugdiscoverytrends.com/nih-announces-…
July 8, 2025 at 6:47 PM
This announcement from the NIH is fantastic
“NIH will no longer seek proposals exclusively for animal models”
All new proposals should include modern alternatives: e.g. computational modeling and organoid style technologies with human components.
drugdiscoverytrends.com/nih-announces-…
“NIH will no longer seek proposals exclusively for animal models”
All new proposals should include modern alternatives: e.g. computational modeling and organoid style technologies with human components.
drugdiscoverytrends.com/nih-announces-…
Sarah Amend: Describing endocyling in cancer dormancy starts by highlighting the lethality of metastatic + therapy resistant cancer cells.
May 6, 2025 at 10:51 AM
Sarah Amend: Describing endocyling in cancer dormancy starts by highlighting the lethality of metastatic + therapy resistant cancer cells.
Guido Ferlazzo: Hepatic stellate cells facilitate the regrowth of dormant cancer cells by reducing NK cell regulation of dormancy in the liver.
May 6, 2025 at 10:45 AM
Guido Ferlazzo: Hepatic stellate cells facilitate the regrowth of dormant cancer cells by reducing NK cell regulation of dormancy in the liver.
Kenneth Pienta: Detecting prostate cancer metastasis with PSMA has changed his understanding of the metastatic cascade.
May 6, 2025 at 10:29 AM
Kenneth Pienta: Detecting prostate cancer metastasis with PSMA has changed his understanding of the metastatic cascade.
Day 2 of Cancer Dormancy and Therapy Resistance workshop.
May 6, 2025 at 10:21 AM
Day 2 of Cancer Dormancy and Therapy Resistance workshop.
Alessandra Riggio, discussing a rapid autopsy program in metastatic breast cancer. Finding disseminated cells undetectable by imaging.
May 5, 2025 at 2:40 PM
Alessandra Riggio, discussing a rapid autopsy program in metastatic breast cancer. Finding disseminated cells undetectable by imaging.
Key takeaway: biology needs math :)
May 5, 2025 at 12:42 PM
Key takeaway: biology needs math :)
Simone Baldassarri: Mathematical aspects of Dormancy for non experts.
Dormancy and migration slow gentic drift and enhance diversity
Dormancy and migration slow gentic drift and enhance diversity
May 5, 2025 at 12:34 PM
Simone Baldassarri: Mathematical aspects of Dormancy for non experts.
Dormancy and migration slow gentic drift and enhance diversity
Dormancy and migration slow gentic drift and enhance diversity
Ann Zeuner asks, is Cancer Dormancy a Trojan horse or an Achille's heel?
May 5, 2025 at 12:03 PM
Ann Zeuner asks, is Cancer Dormancy a Trojan horse or an Achille's heel?
Looking forward to a great conference on Cancer Dormancy and Therapy Resistance.
May 5, 2025 at 11:38 AM
Looking forward to a great conference on Cancer Dormancy and Therapy Resistance.
An important reminder: Science is really difficult.
It's almost a daily conversation in the lab. Remember, 50% of what we do has never been done before. From the simplest experiments to the most indepth review. This stuff is not easy. Be kind and celebrate the wins!
It's almost a daily conversation in the lab. Remember, 50% of what we do has never been done before. From the simplest experiments to the most indepth review. This stuff is not easy. Be kind and celebrate the wins!
January 21, 2025 at 7:31 PM
An important reminder: Science is really difficult.
It's almost a daily conversation in the lab. Remember, 50% of what we do has never been done before. From the simplest experiments to the most indepth review. This stuff is not easy. Be kind and celebrate the wins!
It's almost a daily conversation in the lab. Remember, 50% of what we do has never been done before. From the simplest experiments to the most indepth review. This stuff is not easy. Be kind and celebrate the wins!
Some of my favorite examples of Frequency Dependent Effects, HLA alleles in population immunology and Typanosome variant surface glycoprotein coats and immune evasion.
phys.org/news/2016-05...
phys.org/news/2016-05...
January 21, 2025 at 4:02 PM
Some of my favorite examples of Frequency Dependent Effects, HLA alleles in population immunology and Typanosome variant surface glycoprotein coats and immune evasion.
phys.org/news/2016-05...
phys.org/news/2016-05...
Today's Integrated Mathematical Oncology research in progess talk,
Thomas Veith: Optimizing the Replicator Equation to Model Frequency Dependent Effects in cancer, when Selection favors the rare phenotype. #Oncology
Thomas Veith: Optimizing the Replicator Equation to Model Frequency Dependent Effects in cancer, when Selection favors the rare phenotype. #Oncology
January 21, 2025 at 3:47 PM
Today's Integrated Mathematical Oncology research in progess talk,
Thomas Veith: Optimizing the Replicator Equation to Model Frequency Dependent Effects in cancer, when Selection favors the rare phenotype. #Oncology
Thomas Veith: Optimizing the Replicator Equation to Model Frequency Dependent Effects in cancer, when Selection favors the rare phenotype. #Oncology
Moffitt is hosting a full day retreat on AI in Cancer Careers.
Coding, writing, and patient care.
First take home - always disclose.
Coding, writing, and patient care.
First take home - always disclose.
December 3, 2024 at 2:50 PM
Moffitt is hosting a full day retreat on AI in Cancer Careers.
Coding, writing, and patient care.
First take home - always disclose.
Coding, writing, and patient care.
First take home - always disclose.